Industries > Pharma > Biopharmaceutical Excipients Market Report 2019-2029

Biopharmaceutical Excipients Market Report 2019-2029

By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), by Region and Segment Reports

PAGES: 164
PRODUCT CODE: PHA0511

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1

Biopharmaceutical Excipients is defined as the substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug (biologic) delivery system. The stability of large molecules is intrinsically inferior to small molecules. Research and investments made to address the challenges observed as a result of these facts should drive the market in the future. The profitable growth of the biopharmaceutical industry has created potential opportunities for conventional drug excipients developers to expand their business activities in this market. The market report describes the Biopharmaceutical Excipients such as the Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols and Carbohydrates.

Market Overview and Trends
The growth in this market can be attributed to factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals. Major companies are engaged in improvement of their manufacturing processes to comply with Goods Manufacturing Practice (GMP) requirements. Companies are also embracing initiatives to align with the regulations to achieve EXCiPACT certification which will create the huge impact on the whole industry from the forecast period of 2019-2029.

Factors Influencing the Market Growth:
• Growing pharmaceutical industry combined with advances in biopharmaceutical excipients
• Growing adoption of orphan drugs
• Increasing uptake of biopharmaceuticals
• Rise in outsourcing trend, novel production methods, and reduced timelines for product launches.

Factors Restraining the Market Growth:
• High production costs
• Time-intensive drug development process
• Increasing regulatory stringency

Market Segmentation 2019-2029:
The Biopharmaceutical Excipients market is segmented by Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts

Market Segmentation Covered:
• Global Biopharmaceutical Excipients Product Market 2019-2029
– Global Solubilizers & Surfactants/Emulsifiers Market 2019-2029
– Global Triglycerides Market 2019-2029
– Global Esters Market 2019-2029
– Global Others Market 2019-2029
– Global Polyols Market 2019-2029
– Global Mannitol Market 2019-2029
– Global Sorbitol Market 2019-2029
– Global Others Market 2019-2029
– Global Carbohydrates Market 2019-2029
– Global Sucrose Market 2019-2029
– Global Dextrose Market 2019-2029
– Global Starch Market 2019-2029
– Global Others Market 2019-2029
– Global Specialty Biopharmaceutical Excipients/Others Market 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Biopharmaceutical Excipients market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
ABITEC Corp.; Signet Chemical Corporation Pvt. Ltd.; Roquette; Sigachi Industries Pvt. Ltd.; Meggle AG; Colorcon, Inc.; DFE Pharma; Clariant; IMCD; SPI Pharma; Pharmonix Biological Pvt. Ltd.; Spectrum Chemical Manufacturing Corp., and BASF SE

Key questions answered by this report:
• What is the current size of the total global Biopharmaceutical Excipients market?
• How much will this market be worth from 2018 to 2029?
• How is the Biopharmaceutical Excipients market evolving?
• What is driving and restraining the Biopharmaceutical Excipients market?
• What are the market shares of each segment of the overall Biopharmaceutical Excipients market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each Biopharmaceutical Excipients market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each Biopharmaceutical Excipients market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for Biopharmaceutical Excipients market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the Biopharmaceutical Excipients market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Biopharmaceutical Excipients market. You find data, trends and predictions.

Buy our report today Biopharmaceutical Excipients Market 2019-2029: By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceutical Excipients Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceutical Excipients Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category